2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk
in Adults
Credit Request Instructions
In order to claim AMA PRA Category 1™ credit for viewing the Physician Impairment video, please complete this
exam and return it via email by selecting the Submit button below. If you are unable to submit it electronically,
please fax the exam to the Baptist Health CME Department at 786-533-9706. A certificate will be emailed to you at
the email address provided below within five business days of your submission. A passing score of 75% or higher
is required to receive credit. For any additional questions regarding this course, please call the department at 786596-2398.
I attest that I participated in _________ hour of this activity. (Maximum: 1.0)
Name (Print): __________________________________________________Profession: □ M.D. □ D.O. □ P.A. □ ARNP
Signature: __________________________________________________Date: _____________________
Email Address (Required for certificate): ____________________________________________________
Phone Number: ___________________________
Fax Number: ____________________________
Course Evaluation
Scoring Key: 5-Strongly Agree 4-Agree 3-Neutral 2- Disagree 1-Strongly Disagree N/A-Not applicable to my practice
Please Rate the Following ()
5 4 3
2
1
As a result of viewing this video, to what extent do you agree that you will be better able to:

Examine the risks and benefits of using LDL-C targets.

Identify patients most likely to benefit from statin therapy, and discuss crucial safety
issues of statin therapy
N/A
Scoring Key: 5 - Excellent 4 - Very Good 3 - Good 2 - Fair 1 - Poor N/A - Not applicable
Please Rate the Following
()
Effectiveness of the speaker:
 Neil J. Stone M.D., MACP, FAHA, FACC
Wasthis conference fair, balanced and without commercial bias? [
5
4
3
2
1
N/A
] Yes [ ] No If you checked "No," please explain why:
______________________________________________________________________________________________
Course Examination
Answer Sheet: Please select your answer below.
1. □ a □ b □ c □ d
2. □ a □ b □ c □ d
3. □ a □ b □ c □ d
4. □ a □ b □ c □ d
5. □ a □ b □ c □ d
6. □ a □ b □ c □ d
1. Which of the following is not a “high-risk” statin benefit group
a. Those with documented evidence for atherosclerotic cardiovascular disease (ASCVD)
b. Those with primary elevations of LDL-C ≥ 190 mg/dl
c. Those with diabetes, age 40-75 and LDL-C 70-189
d. Those primary prevention patients with LDL-C <190 and without diabetes, age 40-75 and 10 year
estimated ASCVD risk of ≥ 7.5%
2. In which group is adherence to an optimal heart-healthy lifestyle recommended?
a. Those with documented evidence for atherosclerotic cardiovascular disease (ASCVD)
b. Those with diabetes, age 40-75 and LDL-C 70-189
c. Those primary prevention patients with LDL-C <190 and without diabetes, age 40-75 and 10 year
estimated ASCVD risk of ≥ 7.5%
d. Adherence to a heart healthy lifestyle is recommended in all groups secondary or primary prevention
3. Which statement is true?
a. All of the statins are available as generics
b. Statins lower cardiovascular deaths and stroke, but not total mortality
c. Statins lower total mortality, cardiovascular deaths, and stroke in both primary and secondary
prevention randomized clinical trials
d. Statins never are associated with increased risk of diabetes as seen with niacin
4. Two brothers, age 38 and 41, each have LDL-cholesterol of 180, but have a family history of premature
coronary disease. Their father died of an MI at age 48. What do the guidelines say about whether they
should receive a statin?
a. The guideline indicate that both should be strongly considered for a statin as they have two factors
that can inform the risk decision – LDL-C 160 or more and family history of premature CHD
b. They should not receive a statin; given their young age its unlikely that either is high enough risk
c. The 41 year old may qualify, but the 38 year old is not old enough to use the risk estimator available
on line
d. The guidelines simply don’t discuss family history or LDL cholesterol values under 190
5. Which of the following is true about secondary prevention patients on a statin?
a. Adherence to an optimal lifestyle and a maximally tolerated high-intensity statin is likely to give the
greatest proven ASVD risk reduction
b. Low dose statin and a non-statin that gives equivalent LDL-cholesterol lowering to a maximally tolerated
statin is shown to provide as much risk reduction as a high intensity statin
c. If the LDL-cholesterol is 98 mg/dl (under 100 mg/dl) on a moderate intensity statin (lowers LDL-C
approximately 30-<50%), there is no further risk ASCVD risk reduction a high intensity statin (lowers LDL-C
approximately 50% or more)
d. The cholesterol panel stated that LDL-C goals are not needed in this group
6. Which of the following is not true?
a. A 67 year old man has intermittent right and left calf aching. It has worsened in the past 3 weeks.
Prior to taking the statin, he had no personal or family history of musculoskeletal disorders.
b. The clinician should review recent medications to see if there is one that increases statin concentration.
If he is on simvastatin, starting erythromycin or clarithromycin could lead to statin toxicity due to
interactions with the P450 system.
c. It may be important that he has started to take his statins with 8 oz of grapefruit juice
d. A brief trial off his statin and then a re-challenge can help establish whether the symptom is related
to statin use
SUBMIT